Elisaveta A. Tokarskaya

Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia

Inna V. Dolzhikova, Olga V. Zubkova, Amir I. Tukhvatulin et al. · Human Vaccines & Immunotherapeutics · 2017 · 133 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Virus-Vectored Ebola Vaccines

Inna V. Dolzhikova, Elisaveta A. Tokarskaya, Alina S. Dzharullaeva et al. · Acta Naturae · 2017 · 38 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates

Amir I. Tukhvatulin, Ilya Gordeychuk, Inna V. Dolzhikova et al. · Emerging Microbes & Infections · 2022 · 21 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study

Amir I. Tukhvatulin, Inna V. Dolzhikova, Alina S. Dzharullaeva et al. · Frontiers in Immunology · 2023 · 17 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

A heterologous virus-vectored vaccine for prevention of Middle East respiratory syndrome induces long protective immune response against MERS-CoV

Anna V. Kovyrshina, Inna V. Dolzhikova, Daria M. Grousova et al. · Immunologiya · 2020 · 13 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16